WebAngiotensin II Antagonists Losartan trial (HEAAL) brings to end an era of randomized controlled trials conducted to evaluate the place of angiotensin receptor blockers (ARBs) … WebJan 1, 2024 · HEAAL was an international, multicenter, double-blind, event-driven trial comparing the effect of 2 doses of losartan 150 mg/d (high dose) vs 50 mg/d (low dose) among 3834 patients with symptomatic HF, a left ventricular ejection fraction of 40% or less, stable cardiovascular medical therapy for at least 2 weeks, and known intolerance to …
Renal Function and Heart Failure Treatment
WebNov 17, 2009 · HEAAL was an international, multicentre, double-blind, event-driven trial, comparing the effect of two doses of losartan (Merck, … WebJan 1, 2009 · Konstam MA, Neaton JD, Dickstein K, et al. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a … steve irwin stung by stingray
Effect of patiromer on reducing serum potassium and preventing ...
WebMethods: HEAAL was a double-blind trial, comparing the effect of two doses of losartan 150 (high dose) vs. 50 (low dose) mg/day among 3834 patients with symptomatic HF, a left ventricular ejection fraction≤40 %, and known intolerance to angiotensin-converting enzyme inhibitors. In the present study, we studied the associations of SUA with ... WebMar 28, 2024 · VICTORIA was a multinational, randomized, double-blind, placebo-controlled trial; the trial methods have been described previously. 4 The executive committee designed the trial with national ... WebAs reported in the primary HEAAL trial report, rates of kidney impairment, hyperkalaemia, and hypotension were more common in the 150 mg group than in the 50 mg group (Figure 1). 19 The rates of kidney impairment, hyperkalaemia, and hypotension were 7.1, 2.8, and 2.9 per 100 person-years for patients in this high-dose group and 4.7, 1.9, and 2. ... steve irwin what a beauty